S Rekola

424 total citations
9 papers, 302 citations indexed

About

S Rekola is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, S Rekola has authored 9 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 2 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in S Rekola's work include Renal Diseases and Glomerulopathies (9 papers), Vasculitis and related conditions (2 papers) and Systemic Lupus Erythematosus Research (2 papers). S Rekola is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Vasculitis and related conditions (2 papers) and Systemic Lupus Erythematosus Research (2 papers). S Rekola collaborates with scholars based in Sweden, France and United States. S Rekola's co-authors include Anders Bergstrand, H Bucht, E Pettersson, Ulf Diczfalusy, J Bergström, B Angelin, Ingemar Björkhem, Kristina Sundqvist, O. Broberger and Anita Aperia and has published in prestigious journals such as Kidney International, Clinical & Experimental Immunology and Acta Paediatrica.

In The Last Decade

S Rekola

9 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Rekola Sweden 8 223 52 45 40 39 9 302
Carmen Bernis Spain 8 204 0.9× 53 1.0× 46 1.0× 74 1.9× 40 1.0× 14 360
Jane Hattersley United Kingdom 10 319 1.4× 70 1.3× 42 0.9× 53 1.3× 56 1.4× 15 422
Clark Wf Canada 12 102 0.5× 72 1.4× 42 0.9× 33 0.8× 21 0.5× 14 310
Yoshitaka Koshino Japan 8 229 1.0× 36 0.7× 53 1.2× 48 1.2× 39 1.0× 28 333
Hisanori Morimoto Japan 8 99 0.4× 39 0.8× 19 0.4× 22 0.6× 41 1.1× 15 269
Patrick Biggar Germany 12 196 0.9× 99 1.9× 58 1.3× 44 1.1× 21 0.5× 25 375
Haruo Mitani Japan 9 252 1.1× 37 0.7× 47 1.0× 71 1.8× 76 1.9× 21 478
Filippo Mangione Italy 9 112 0.5× 61 1.2× 26 0.6× 21 0.5× 28 0.7× 16 269
Hiroshi Kinashi Japan 10 144 0.6× 22 0.4× 79 1.8× 31 0.8× 46 1.2× 41 301
Evelyn Alonzo Venezuela 9 130 0.6× 93 1.8× 89 2.0× 46 1.1× 64 1.6× 10 360

Countries citing papers authored by S Rekola

Since Specialization
Citations

This map shows the geographic impact of S Rekola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Rekola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Rekola more than expected).

Fields of papers citing papers by S Rekola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Rekola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Rekola. The network helps show where S Rekola may publish in the future.

Co-authorship network of co-authors of S Rekola

This figure shows the co-authorship network connecting the top 25 collaborators of S Rekola. A scholar is included among the top collaborators of S Rekola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Rekola. S Rekola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Baskin, Berivan, E Pettersson, S Rekola, Smith Rjh, & Khalid B. Islam. (1996). Studies of the molecular basis of IgA production, subclass regulation and class-switch recombination in IgA nephropathy patients. Clinical & Experimental Immunology. 106(3). 509–517. 16 indexed citations
2.
Pettersson, E, S Rekola, Kristina Sundqvist, et al.. (1994). Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study.. PubMed. 41(4). 183–90. 84 indexed citations
3.
Rekola, S, Anders Bergstrand, & H Bucht. (1991). Deterioration Rate in Hypertensive IgA Nephropathy: Comparison of a Converting Enzyme Inhibitor and β-Blocking Agents. ˜The œNephron journals/Nephron journals. 59(1). 57–60. 40 indexed citations
4.
Rekola, S, et al.. (1991). Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney International. 40(6). 1050–1054. 63 indexed citations
5.
Rekola, S, Anders Bergstrand, & H Bucht. (1990). Development of Hypertension in IgA Nephropathy as a Marker of a Poor Prognosis. American Journal of Nephrology. 10(4). 290–295. 23 indexed citations
6.
Rekola, S, Anders Bergstrand, & H Bucht. (1989). IgA Nephropathy: A Retrospective Evaluation of Prognostic Indices in 176 Patients. Scandinavian Journal of Urology and Nephrology. 23(1). 37–50. 26 indexed citations
7.
Rekola, S, A Bergstrand, H Bucht, & Alf A. Lindberg. (1985). Are beta-haemolytic streptococci involved in the pathogenesis of mesangial IgA-nephropathy?. PubMed. 21. 698–702. 7 indexed citations
8.
Linné, Tommy, Anita Aperia, O. Broberger, et al.. (1982). COURSE OF RENAL FUNCTION IN IgA GLOMERULONEPHRITIS IN CHILDREN AND ADOLESCENTS. Acta Paediatrica. 71(5). 735–743. 27 indexed citations
9.
Asaba, H, S Rekola, Anders Bergstrand, Hal S. Wasserman, & Jonas Bergström. (1980). Clinical trial of plasma exchange with a membrane filter in treatment of crescentic glomerulonephritis.. PubMed. 14(2). 60–5. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026